JC Telemedicine was founded in 2019 to provide services to companies that want to use telemedicine. At the beginning of this year, it spun off a product-focused company called Telepath.
Telepath is the “accumulation of learnings” over the years and is where Jeff Carroll, the director spends time growing his online offering.
1) COVID-19 boosted the need for telemedicine solutions. How does Telepath plan to keep up the momentum?
Telepath is an enabler for telemedicine solutions. We’re the one-stop-shop for digital health: Customized web application for your patients? Check. Medication e-commerce? Check. Integrated API? Check. Telepath has developed a telehealth solution that integrates with your life and practice. We plan to aggressively scale the number of physicians that utilize our software to enable greater adoption of telehealth.
2) Which new projects are being handled by Telepath?
Telepath is working on some really exciting projects. Everything for us comes back to the affordability and accessibility of medications. Most disadvantaged and minority populations don’t have a credit card or bank account, and we’re solving this problem by letting patients pay for their medications in cash. We’re also partnered with a network of low-cost pharmacies that help us pass wholesale pricing directly to patients via the physicians’ websites.
3) What’s your take on the telemedicine market? What are the innovations/trends that are notable?
There is an enormous gap between healthcare providers who want to go digital and patients who want digital care. Widespread use of telemedicine:
A) Reduces friction
B) Reduces cost
C) Expands the reach of healthcare
Doctors aren’t equipped to build their own virtual care platforms and don’t know where to start. But we see some very exciting trends. For example, more doctors are using the power of the Internet to grow his/her practice. With Telepath, doctors can create digital businesses to reach more patients in their states/ clinical arenas and treat patients digitally within minutes.
4) Telepath was founded in 2022; as a relatively new entrant in the market, what challenges you faced, and how did you overcome them?
We face new challenges every day. The telemedicine legal landscape is constantly changing, and we see every state in the US at a different starting point. The pandemic helped evolve antiquated laws and regulations, but we still have a long way to go. Our strategy is to always follow the letter of the law but also to help educate doctors on what those boundaries look like and how to find the balance between progressive and lawful actions. We have also met resistance on other topics like compliance, payment processing, and more–the list goes on and on. We find that by educating ourselves and thinking outside the box, we can help doctors achieve the most fantastic results by transforming their practices to digital.
5) Post-pandemic many restrictions have been loosened regarding mobile activities, and patients can now reach clinics. How do you perceive this changing scenario?
We believe everything in healthcare should revolve around the doctor and patient relationship. Nobody should interfere with the patient’s ability to choose their doctor, and nothing should interfere with how the doctor chooses to treat his/her patients. As D2C care grows, physicians miss out on an opportunity to provide cutting-edge care. We believe that if the tools to create digital practices become more widely available to physicians, everyone wins.
6) How does Telepath plans to scale its business?
Telepath is the software company that powers the digital practices of tomorrow. Eventually, we hope to be the go-to system for any doctor that wants to create a fully digital or hybrid-style practice. We’re excited about our launching-soon partnership opportunities but most excited about supporting local practices to grow and thrive. We use an organic, direct sales strategy to help educate solo and group practices about their options when they decide to complement their practice with telemedicine.